gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in Acromegaly

SIMPLE SUMMARY: Acromegaly treatment consists of surgical, medical, and radiation therapy. First-generation somatostatin receptor ligands are the mainstay of medical therapy, with approximately 40% disease control rate. Several parameters have been evaluated as predictors of response to these drugs,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wildemberg, Luiz Eduardo, Henriques, Daniel, Elias, Paula C. L., Lima, Carlos Henrique de A., Musolino, Nina R. de Castro, Camacho, Aline Helen Silva, Faria, Olivia, Nazato, Debora, Abucham, Julio, Vilar, Lucio, Mota, Jose Italo, Huayllas, Martha Katherine P., Chimelli, Leila, de Castro, Margaret, Kasuki, Leandro, Gadelha, Mônica R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508484/
https://www.ncbi.nlm.nih.gov/pubmed/34638340
http://dx.doi.org/10.3390/cancers13194857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508484/
https://www.ncbi.nlm.nih.gov/pubmed/34638340
http://dx.doi.org/10.3390/cancers13194857

Ejemplares similares